Parkinson's Disease Research

Parkinson's disease (PD) is a degenerative disease of the central nervous system that often impairs motor skills, speech, and other functions. Symptoms of the disease include resting tremor, bradykinesia and rigidity. The primary symptoms are the result of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Symptoms of the disease appear once 50-80% of dopamine neurons have died. Parkinson's disease is both chronic and progressive.

Parkinson's Disease Research Products Targets

Products for Parkinson's Disease Research - Page 66

  1. Cat.No. Product Name Information/Activity
  2. BCC7653 NPEC-caged-(1S,3R)-ACPD 1315379-60-2 NPEC-caged-(1S,3R)-ACPD chemical structure
  3. BCC6558 S-Sulfo-L-cysteine sodium salt 7381-67-1 S-Sulfo-L-cysteine sodium salt chemical structure
  4. BCC7302 ACDPP hydrochloride 37804-11-8 ACDPP hydrochloride chemical structure
  5. BCC6841 AIDA 168560-79-0 AIDA chemical structure
  6. BCC2459 DL-AP3 Phosphoserine phosphatase inhibitor DL-AP3 chemical structure
  7. BCC5915 Bay 36-7620 Non-competitive mGlu<sub>1</sub> antagonist with inverse agonist activity Bay 36-7620 chemical structure
  8. BCC6607 (S)-3-Carboxy-4-hydroxyphenylglycine 55136-48-6 (S)-3-Carboxy-4-hydroxyphenylglycine chemical structure
  9. BCC6600 (S)-4-Carboxy-3-hydroxyphenylglycine 85148-82-9 (S)-4-Carboxy-3-hydroxyphenylglycine chemical structure
  10. BCC6603 (S)-4-Carboxyphenylglycine 134052-73-6 (S)-4-Carboxyphenylglycine chemical structure
  11. BCC6896 CPCCOEt 179067-99-3 CPCCOEt chemical structure

Items 651 to 660 of 752 total